Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

531
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
531
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

35
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paving the physician-scientist career path: from grassroots gathering to national forum.

JCI insight·2025
Same author

Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression.

Breast cancer research and treatment·2024
Same author

Is it time to reduce the length of postgraduate training for physician-scientists in internal medicine?

JCI insight·2024
Same author

Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor.

Frontiers in endocrinology·2023
Same author

Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy.

Current problems in cancer. Case reports·2023
Same author

Unregulated LDL cholesterol uptake is detrimental to breast cancer cells.

Endocrine-related cancer·2022

Related Experiment Video

Updated: May 2, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
06:55

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

20.8K

Diabetes and cancer.

Zara Zelenko1, Emily Jane Gallagher1

  • 1Division of Endocrinology, Diabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1055, New York, NY 10029, USA.

Endocrinology and Metabolism Clinics of North America
|March 4, 2014
PubMed
Summary

Type 2 diabetes (T2D) is linked to higher cancer risk and mortality. This review explores biological mechanisms connecting T2D, obesity, and metabolic syndrome to cancer, aiming to improve patient outcomes.

Keywords:
CancerDiabetes mellitusHyperglycemiaHyperinsulinemiaInflammationMetabolic syndromeObesity

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

12.6K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.9K

Related Experiment Videos

Last Updated: May 2, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
06:55

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

20.8K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

12.6K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.9K

Area of Science:

  • Endocrinology
  • Oncology
  • Metabolic Syndrome Research

Background:

  • Diabetes mellitus, particularly type 2 diabetes (T2D), is a global health concern.
  • Epidemiological data indicate a significant association between T2D and an increased risk of developing various cancers.
  • Patients with T2D often exhibit higher cancer-related mortality rates.

Purpose of the Study:

  • To review and elucidate the biological mechanisms underlying the established link between type 2 diabetes and cancer.
  • To explore the interconnectedness of T2D, obesity, and metabolic syndrome in the context of cancer development.
  • To identify potential therapeutic targets for reducing mortality in individuals with both T2D and cancer.

Main Methods:

  • Comprehensive literature review of epidemiological studies and biological research.
  • Analysis of proposed mechanistic pathways connecting metabolic dysregulation to oncogenesis.
  • Synthesis of current understanding regarding the roles of insulin resistance, inflammation, and hormonal imbalances.

Main Results:

  • Multiple biological mechanisms are proposed to explain the T2D-cancer association, including hyperinsulinemia, chronic inflammation, and altered adipokine signaling.
  • Obesity and metabolic syndrome are identified as significant contributing factors that exacerbate the T2D-cancer link.
  • The review consolidates current knowledge on the complex interplay between metabolic health and cancer risk.

Conclusions:

  • Understanding the precise biological mechanisms is crucial for developing targeted interventions.
  • Effective management of T2D, obesity, and metabolic syndrome may reduce cancer risk and improve survival.
  • Further research into these mechanisms can lead to novel therapeutic strategies for comorbid T2D and cancer patients.